Le false novità della ricerca clinica

Translated title of the contribution: False innovations of the clinical research

Research output: Contribution to journalArticle

Abstract

Pharmaceutical innovation is actually poorer than it seems, largely because of "false" innovations. Various factors help create an image of novelty in the pharmaceutical area. These factors act throughout the research and development process and in the post-marketing stages affecting the selection of study hypotheses, the adoption of the appropriate study methodology, and the interpretation and publication of results. Each of these steps may be diverted from the priority objective of patients' interest and shifted towards to the defence of the drugs companies' commercial interests. Regulators, NHS, physicians and patients must be vigilant to recognise and get rid of false innovations which can prevent the use of more effective and safer drugs and waste resources useful for effective treatments in other areas. Rewarding this lack of innovation discourages research for excellence and reduces the competitiveness of the pharmaceutical industry.

Translated title of the contributionFalse innovations of the clinical research
Original languageItalian
Pages (from-to)611-617
Number of pages7
JournalRecenti Progressi in Medicina
Volume97
Issue number11
Publication statusPublished - Nov 2006

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'False innovations of the clinical research'. Together they form a unique fingerprint.

  • Cite this